AVAI BIO, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
AVAI BIO, INC. (AVAI) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $60.44 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-13
- AVAI BIO, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-06-30 was $60.44K.
- AVAI BIO, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-06-30 was -$70.99K, a 43652.76% decline year-over-year.
- AVAI BIO, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-06-30 was $163.00.
- AVAI BIO, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-06-30 was -$106.95K.
- AVAI BIO, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2026 was -$57.91K, a 171.69% decline from fiscal 2025.
- AVAI BIO, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $80.77K.
- AVAI BIO, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$107.19K, a 244.50% decline from fiscal 2023.
- AVAI BIO, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $74.18K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $60.44K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | -$57.91K 10-K · filed 2026-07-14 | |||
| 2025-12-31 | -$30.65K 10-Q · filed 2026-02-12 | |||
| 2025-09-30 | $10.94K 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | -$70.99K 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | $80.77K 10-K · filed 2026-07-14 | |||
| 2024-12-31 | $2.79K 10-Q · filed 2026-02-12 | |||
| 2024-09-30 | $1.49K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $163.00 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | -$107.19K 10-K · filed 2025-07-08 | |||
| 2023-12-31 | -$106.58K 10-Q · filed 2025-02-07 | |||
| 2023-09-30 | -$105.99K 10-Q/A · filed 2025-01-21 | |||
| 2023-06-30 | -$106.95K 10-Q/A · filed 2025-01-21 | |||
| 2023-03-31 | $74.18K 10-K/A · filed 2025-02-19 | |||
| 2022-12-31 | -$14.48K 10-Q · filed 2024-02-14 |